Research article · 24 Feb 2025
Conference abstractPublished 27 Nov 2023
External validation of the residual cancer Burden Index for predicting survival in breast cancer patients undergoing neoadjuvant chemotherapy: A Brazilian population study
Setor de Mastologia da Disciplina de Ginecologia do Departamento de ObstetrÃ?cia e Ginecologia, Hospital das Clinicas da Faculdade de Medicina da Universidade de SÃ?£o Paulo, SÃ?£o Paulo, Brazil.
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Introduction: The significance of complete pathological response (pCR) as a prognostic factor in breast cancer patients undergoing neoadjuvant chemotherapy was established by the NSABP-B27 study. Subsequently, the Residual Cancer Burden (RCB) score was developed to assess the impact of incremental pathological response improvements beyond pCR on patient outcomes. In this study, we present an external validation of the RCB score in a diverse Brazilian population. Objectives: This study aims to investigate the correlation between the Residual Cancer Burden (RCB) index and both overall survival (OS) and disease-free survival (DFS) in women who underwent neoadjuvant chemotherapy at the Cancer Institute of the State of SÃ?£o Paulo. Methods: We conducted a retrospective analysis of medical records from breast cancer patients who received neoadjuvant chemotherapy and breast surgery between 2011 and December 2017. Variables examined included age, clinical and pathological staging, molecular subtype, recurrence/metastasis count, mortality count, as well as the value and classification of the residual cancer burden index. We employed Kaplan-Meier and Log-rank statistical methods to assess the association between RCB and OS/DFS. A regression model was applied to determine the independent relationship between RCB and outcomes, while accounting for confounding factors. Results: The analysis comprised 347 patients, with a mean age of 49.39 years. Initial clinical staging revealed that 57.9% of patients had T3 stage, and 43.8% exhibited N1 axillary status. Survival analysis indicated a statistically significant favorable prognosis in the RCB 0 subgroup (pCR) compared to RCB 1, 2, and 3 subgroups (Log-rank p = 0.01). In a multivariate analysis, the RCB classification emerged as the sole factor significantly correlated with disease-free survival: RCB-1 (HR 6.9, CI 1.9 - 25.4, p = 0.004), RCB-2 (HR 4.2, CI 1.6 âÂ?Â? 10.8, p = 0.03), and RCB-3 (HR 7.6, CI 2.76 âÂ?Â? 20.8, p = 0.00). Conclusion: This study establishes a robust and meaningful relationship between the RCB index and the risk of relapse and mortality. The findings reinforce the utility of the RCB score as a valuable predictive tool for assessing patient outcomes following neoadjuvant chemotherapy in breast cancer patients, even within the diverse Brazilian population.
Subjects
Pathology & Lab MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Clinical & Experimental Pathology.
Research article · 3 Feb 2025
Outbreak of Crimean Congo Haemorrhagic Fever in Northern Senegal in 2022
Review article · 16 Jan 2025
Recent Updates on Huntington Disease
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical & Experimental Pathology
- SubjectPathology & Lab Medicine
- BylineArticles whose byline prints “Rodrigo Goncalves”
- BylineArticles whose byline prints “Juliana Pierobon Gomes da Cunha”
- BylineArticles whose byline prints “Fernando Silva”
- BylineArticles whose byline prints “Fernando Nalesso Aguiar”
- BylineArticles whose byline prints “Bruna Salani Mota”
- BylineArticles whose byline prints “Bruna Bello Chequim”
- BylineArticles whose byline prints “JosÃ?© Maria Soares Jr”
- BylineArticles whose byline prints “Edmund Chada Baracat”